Gene: ZNF225

7768
-
zinc finger protein 225
protein-coding
19q13.31
Ensembl:ENSG00000256294 Vega:OTTHUMG00000182336 UniprotKB:Q9UK10
NC_000019.10
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.575e-1 (AD)  5.859e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs10413195chr19:44130750 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs10413511chr19:44130658 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs9304638chr19:44129933 (GRCh38.p7)C>G / C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10406335chr19:44129800 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs2284981chr19:44129405 (GRCh38.p7)G>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2284980chr19:44129321 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2168778chr19:44127066 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs7508762chr19:44125725 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs10853771chr19:44125295 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs7251868chr19:44124204 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs4802208chr19:44123759 (GRCh38.p7)G>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2356750chr19:44121756 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs7253485chr19:44120889 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs8099869chr19:44119223 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs2300962chr19:44116050 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs2284978chr19:44113157 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg10786870chr19:44616116ZNF225Promoter7.764e-4Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
XPO40.851
MED230.844
MLLT100.831
POLH0.829
GEMIN50.829
ZMYM60.829
MED140.827
ZNF1750.827
ACVR2B0.823
FKTN0.823

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.365
OR4F29-0.333
KLRC2-0.288
VAX2-0.287
BCL7C-0.287
NANOGNB-0.265
HMX1-0.256
S100A14-0.256
PLA2G5-0.248
S100A1-0.247

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
D016604Aflatoxin B1Aflatoxin B1 results in increased methylation of ZNF225 gene27153756
D000535Aluminum[APP protein modified form binds to Aluminum] which results in increased expression of ZNF225 mRNA21298039
D000638AmiodaroneAmiodarone results in increased expression of ZNF225 mRNA19774075
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF225 mRNA28628672
D019327Copper SulfateCopper Sulfate results in increased expression of ZNF225 mRNA19549813
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF225 mRNA28628672
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in increased expression of ZNF225 mRNA23649840
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF225 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF225 mRNA28628672
C544151jinfukangjinfukang results in decreased expression of ZNF225 mRNA27392435
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of ZNF225 mRNA28001369
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of ZNF225 mRNA23649840
D010936Plant ExtractsPlant Extracts results in increased expression of ZNF225 mRNA23557933
D011794QuercetinQuercetin results in increased expression of ZNF225 mRNA21632981
D014750VincristineVincristine results in decreased expression of ZNF225 mRNA23649840

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISA-  
GO:0003677DNA binding-IEA-  
GO:0046872metal ion binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006351transcription, DNA-templated-IEA-  
GO:0006357regulation of transcription by RNA polymerase II-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-212436Generic Transcription PathwayTAS
R-HSA-73857RNA Polymerase II TranscriptionTAS
R-HSA-74160Gene expression (Transcription)TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal